title: Therapy of cutaneous lymphoma--current practice and future developments.
abstract: Cutaneous lymphomas include various types of clonal lymphoproliferative disorders. The adequate treatment approach depends on the exact diagnosis and should be non-aggressive in most cases. In early stages, local approaches such as UV or radiotherapy are preferred. In advanced stages, systemic drugs such as interferon-alpha or bexarotene can be administered. Experimental approaches for cutaneous lymphomas include vaccination and gene therapy.
authors.affiliation: Department of Dermatology, University Hospital of Zurich, Switzerland. reinhard.drummer@usz.ch
authors.forename: R
authors.initials: R
authors.lastname: Dummer
authors.forename: W
authors.initials: W
authors.lastname: Kempf
authors.forename: M
authors.initials: M
authors.lastname: Hess Schmid
authors.forename: A
authors.initials: A
authors.lastname: Häffner
authors.forename: G
authors.initials: G
authors.lastname: Burg
mesh_terms: D006801:Humans; D016393:Lymphoma, B-Cell / Q000473:pathology / Q000628:therapy*; D016410:Lymphoma, T-Cell, Cutaneous / Q000473:pathology / Q000628:therapy*; D009182:Mycosis Fungoides / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging; D011379:Prognosis; D012751:Sezary Syndrome / Q000473:pathology / Q000628:therapy*; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000473:pathology / Q000628:therapy*